Gaithersburg, MD, United States of America

Scott A Hammond

This inventor holds 19 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Bispecific Binding Proteins. Top assignee: Medimmune Limited. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott A Hammond. Retrieved from https://idiyas.com/inventor/scott-a-hammond

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 9)

% Patents Active = 89.5

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 5 (Patent Applications = 15)

Average Co-Inventor Count = 8.9

ph-index = 6

Forward Citations = 258(Granted Patents)

Location History:

Olney, MD (US) (2016 - 2022)
Gaithersburg, MD (US) (2014 - 2024)

Company Filing History:

19 out of 548

Medimmune Limited

patents

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

B7-H1

CD73

PD-1

TIGIT

Binding Agents

Cancer Treatment

Humanized Antibodies

OX40

Fusion Proteins

Protein Formulation

Molecules

Targeted Therapy

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12686718 - TARGETED BINDING AGENTS AGAINST B7-H1 (2026-07-21),

2. 12630648 - BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF (2026-05-19),

3. 12570744 - BISPECIFIC PD-1 AND TIGIT BINDING PROTEINS AND USES THEREOF (2026-03-10),

4. RE49908 - Bispecific binding proteins and uses thereof (2024-04-09),

5. 11939382 - Bispecific PD-1 and TIGIT binding proteins and uses thereof (2024-03-26),

6. 11525012 - Binding molecules specific for CD73 and uses thereof (2022-12-13),

7. 11518809 - Targeted binding agents against B7-H1 (2022-12-06),

8. 11279759 - Bispecific binding proteins and uses thereof (2022-03-22),

9. 10556968 - Binding molecules specific for CD73 and uses thereof (2020-02-11),

10. 10457732 - Bispecific binding proteins and uses thereof (2019-10-29),

11. 10400039 - Targeted binding agents against B7-H1 (2019-09-03),

12. 10287362 - Binding molecules specific for CD73 and uses thereof (2019-05-14),

13. 10150815 - Method of treating cancer with humanized anti-OX40 antibodies (2018-12-11),

14. 9938356 - Binding molecules specific for CD73 and uses thereof (2018-04-10),

15. 9738723 - Humanized anti-OX40 antibodies and uses thereof (2017-08-22),

Title: The Innovative Journey of Scott A Hammond

Introduction: Scott A Hammond, a talented inventor hailing from Gaithersburg, MD, has made significant contributions to the world of innovation with his creative mind and dedication to progress.

Latest Patents: Scott A Hammond's latest patents showcase his commitment to pushing boundaries and exploring new ideas in various industries, from technology to healthcare.

Career Highlights: Throughout his illustrious career, Scott A Hammond has been recognized for his groundbreaking inventions that have revolutionized the way we live and work. His innovative spirit has led to numerous successful ventures and collaborations.

Collaborations: Scott A Hammond's collaborative efforts with leading companies, research institutions, and universities have resulted in the development of cutting-edge technologies that have had a lasting impact on society.

Conclusion: In conclusion, Scott A Hammond's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.